These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 18822656)

  • 21. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
    Edelman AB; Koontz SL; Nichols MD; Jensen JT
    Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Contraception].
    Colau JC
    Gynecol Obstet Fertil; 2000 Jun; 28(6):460-6. PubMed ID: 10935312
    [No Abstract]   [Full Text] [Related]  

  • 24. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
    Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [What does the micropill bring?].
    Mall-Haefeli M
    Ther Umsch; 1986 May; 43(5):365-71. PubMed ID: 2941889
    [No Abstract]   [Full Text] [Related]  

  • 26. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
    Urdinola J
    Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
    [No Abstract]   [Full Text] [Related]  

  • 27. Ectopic pregnancy following emergency contraception with ethinyloestradiol-levonorgestrel: a case report.
    Matsushita H; Takayanagi T; Ikarashi H
    Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):184-6. PubMed ID: 17559018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran.
    Kashanian M; Shahpourian F; Zare O
    Eur J Obstet Gynecol Reprod Biol; 2010 May; 150(1):47-51. PubMed ID: 20185226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial.
    Oddsson K; Leifels-Fischer B; Wiel-Masson D; de Melo NR; Benedetto C; Verhoeven CH; Dieben TO
    Hum Reprod; 2005 Feb; 20(2):557-62. PubMed ID: 15539438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of levonorgestrel implants on the periodontium.
    Kazerooni T; Ghaffarpasand F; Rastegar N; Kazerooni Y
    Int J Gynaecol Obstet; 2008 Dec; 103(3):255-6. PubMed ID: 18804758
    [No Abstract]   [Full Text] [Related]  

  • 31. A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 microg of ethinylestradiol and 100 microg of levonorgestrel with 30 microg of ethinylestradiol and 100 microg of levonorgestrel.
    Jespersen J; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Sidelmann JJ; Skouby SO
    Contraception; 2005 Aug; 72(2):98-104. PubMed ID: 16022847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America.
    Moggia AV
    J Reprod Med; 1983 Jan; 28(1 Suppl):77-80. PubMed ID: 6403704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of myocardial infarction in oral-contraceptive users.
    Shapiro S; Slone D; Miettinen OS
    Lancet; 1979 Jul; 2(8135):194. PubMed ID: 89297
    [No Abstract]   [Full Text] [Related]  

  • 34. Mesenteric venous thrombosis associated with pregnancy and oral contraception. A case report.
    Graubard ZG; Friedman M
    S Afr Med J; 1987 Apr; 71(7):453. PubMed ID: 3563797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levonorgestrel versus the "Yuzpe" regimen. New choices in emergency contraception.
    Lee SM; Dunn S; Evans MF
    Can Fam Physician; 1999 Mar; 45():629-31. PubMed ID: 10099801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 microg or 30 microg) and levonorgestrel (100 microg or 150 microg) on lipoprotein metabolism.
    Scharnagl H; Petersen G; Nauck M; Teichmann AT; Wieland H; März W
    Contraception; 2004 Feb; 69(2):105-13. PubMed ID: 14759614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in hormonal contraception.
    Gupta N
    Adolesc Med Clin; 2006 Oct; 17(3):653-71; abstract xi. PubMed ID: 17030284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral contraceptive, pulmonary artery thrombosis and anti-ethinyl-oestradiol monoclonal IgG.
    Beaumont JL; Lemort N
    Clin Exp Immunol; 1976 Jun; 24(3):455-63. PubMed ID: 820501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxic epidermal necrolysis secondary to emergency contraceptive pills.
    Weinberger CH; Bhardwaj SS; Bohjanen KA
    J Am Acad Dermatol; 2009 Apr; 60(4):708-9. PubMed ID: 19293026
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives.
    Vasilakis-Scaramozza C; Jick H
    Lancet; 2001 Oct; 358(9291):1427-9. PubMed ID: 11705493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.